Background/Purpose: Proteus mirabilis is a common pathogen responsible for complicated urinary tract infections (UTIs) that sometimes causes bacteremia. Most cases of P. mirabilis bacteremia originate from a UTI; however, the risk factors for bacteremia and mortality rates from P. mirabilis UTI have not been determined. Methods: A retrospective, case-control study was performed between May 2008 and November 2010 to identify the risk factors and markers for P. mirabilis bacteremic UTI. Each subject in the case group (all patients were diagnosed with P. mirabilis bacteremia from a urinary tract source) was matched by age and gender to two subjects in the control group (patients diagnosed with P. mirabilis UTI but with negative blood culture results). Clinical presentation and laboratory data were analyzed to determine the risk factors and markers of P. mirabilis bacteremic UTI. Results: Sixty-seven bacteremic UTIs and 124 nonbacteremic UTIs were included in this study. Community-acquired infection (p Z 0.017), hydronephrosis (p Z 0.017), band neutrophils accounting for >10% of the white blood cell count (p Z 0.001), hyperthermia or hypothermia (p Z 0.047), and a serum C-reactive protein concentration >100 mg/L (p Z 0.002) were identified as independent risk factors for P. mirabilis bacteremic UTI. Seventeen patients died in hospital, including 11 in the bacteremic group and 6 in the nonbacteremic group. The bacteremic group had a higher mortality rate (p Z 0.016). Bacteremic UTI (p Z 0.049), shock (p Z 0.014), and a low body mass index (BMI) <18 kg/m 2 (p Z 0.033) were identified as independent risk factors for mortality. Conclusion: Because bacteremic P. mirabilis UTIs are associated with higher mortality, clinicians should carefully manage cases that present with the risk factors for bacteremia, including community-acquired infection, hydronephrosis, band neutrophils accounting for >10% of the white blood cell count, hyperthermia or hypothermia, and a high level of C-reactive protein.
Introduction
Proteus mirabilis is a member of the Enterobacteriaceae family and is a highly motile bacterium. 1 Unlike the other members of Enterobacteriaceae, P. mirabilis is not a common pathogen that causes urinary tract infections (UTIs) in normal hosts. 2, 3 In contrast, P. mirabilis is isolated relatively frequently in complicated UTIs, such as those that present in patients with functional or anatomical abnormalities, especially patients with urolithiasis or a chronic indwelling urinary catheter. 4 P. mirabilis is well known for its ability to produce urease, which generates ammonia and elevates the pH of the urine to >7.2.
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Calcium and magnesium crystallization in the urine of alkaline pH blocks the catheter lumen and causes acute urinary retention and the development of bacteriuria and other ascending infections, thereby leading to pyelonephritis, bacteremia, and shock. 6 P. mirabilis is susceptible to b-lactams, aminoglycosides, fluoroquinolones, and trimethoprim/sulfamethoxazole, but is resistant to nitrofurantoin and tetracycline. 7 In recent years, a trend has been observed where Enterobacteriaceae species, including P. mirabilis, show increased resistance to several antimicrobial agents. 8, 9 This increased resistance to antimicrobial agents has led not only to a changes in antimicrobial therapies, but also to poor prognoses and an increase in the mortality rate of hospitalized patients. 10 Although the risk factors and clinical outcomes of bloodstream infections originating from extended spectrum b-lactamase (ESBL)-positive Escherichia coli and Klebsiella pneumoniae have been investigated recently, 11e14 bacteremic UTIs caused by P. mirabilis are relatively uncommon and, to date, have been less thoroughly studied. Furthermore, previous studies show that patients with bactermic UTIs present with more severe systemic inflammatory response syndrome (SIRS) and higher mortality rates than patients without bacteremia. 18, 19 Thus, we conducted a retrospective, matched, casecontrol study in patients with P. mirabilis bacteremic UTIs. The aims of our study were to (1) determinate the relative risk factors of P. mirabilis bacteremic UTIs, (2) investigate the risk factors related to mortality, and (3) compare the resistance profiles of P. mirabilis between these two groups of patients.
Methods
Study setting and population Our retrospective, matched, case-control study compares bacteremic and nonbacteremic patients with P. mirabilis UTIs who were recruited from the Kaohsiung Medical University Hospital (KMUH), a 1600-bed medical center located in Kaohsiung City in southern Taiwan.
Patients were retrospectively identified from the microbiology databases at KMUH and data were prospectively collected from May 1, 2008 through November 30, 2010. Medical records were reviewed by two infectious disease specialists. Data on the following variables were collected: age, gender, date of admission, diagnosis, outcome, and in vitro antimicrobial susceptibility. This study protocol was approved by the Institutional Review Board of KMUH.
Determination of case controls
Patients from whom a urinary culture was obtained, but not a blood culture, and those younger than 18 years of age were excluded. Blood cultures were collected from all enrolled patients. Patients with a positive blood culture from a source other than a UTI, such as a decubitus ulcer or an intra-abdominal infection, were also excluded from this study. Patients with a UTI and bacteremia due to P. mirabilis were identified as cases, while patients with a UTI and no bacteremia were identified as controls. Cases and controls were matched for age (AE5 years) and sex; the case:control ratio was 1:2.
Case definition
P. mirabilis bacteremic UTIs were defined by a positive urine culture with >10 5 colony-forming units (cfu)/mL and isolation of the same strain of P. mirabilis from both the urine and blood from the same patient at the same time. 20 Control P. mirabilis UTI cases without bacteremia were defined by a positive urine culture in the presence of >10 5 cfu/mL accompanied by one of the following: (1) signs of a UTI, such as fever, dysuria, increased frequency of micturition, back or flank pain, or costovertebral angle tenderness; (2) pyuria 21 ; or (3) a nonspecific decline in functions or symptoms that could not be attributed to an obvious source of infection other than UTI. 22 A patient was considered febrile when the highest recorded tympanic temperature was >38.0 C on the day the blood culture was collected. 23 Kidney failure was defined as a creatinine level >1.5 mg/dL, 24 and co-morbid conditions (such as cirrhosis, diabetes, etc.) or immunocompromised status were ascertained according to the patient's medical records and Charlson's score; 25 these findings were reviewed by two infectious disease specialists. Nosocomial infections were defined as (1) infections occurring more than 48 hours after hospital or emergency department admission or (2) if patients were referred from another hospital or healthcare facility. 26 Chronic or long-term urinary catheterization was defined as catheterization for more than 7 days prior to specimen collection for bacterial culturing. 27 A urological abnormality was defined as either the presence of urinary tract obstructions, urethral strictures, urolithiasis, benign prostate hyperplasia, congenital abnormalities, or functional problems such as neurogenic bladder or vesicoureteral reflux. A shock episode was defined as a systolic pressure <90 mmHg or the use of inotropic agents to maintain blood pressure for at least 1 hour.
Imaging studies of every case were reviewed whenever possible, and abdominal computed tomography (CT) scan, kidney, ureter, and bladder (KUB) x-rays, or sonographic results were all recorded. We tried to identify whether hydronephrosis or urolithiasis was present in each case. The initial antimicrobial therapy was considered appropriate if at least one antimicrobial agent was active in vitro according to Clinical and Laboratory Standards Institute (CLSI) guidelines and was administrated within 48 hours after all samples were collected for culturing. 27 During the study period, a patient was considered to have had two individual episodes when there was complete remisson of fever, leukocytosis, and local signs of infection more than 1 month after the discontinuation of any antimicrobial therapy that was administered to treat the first UTI episde. 28 
Microbiological methods
Blood culture samples were collected in aerobic and anaerobic bottles and were cultured using the BACT/Alert 3D system (Becton Dickinson Microbiology Systems, Sparks, MD, USA). The Vitek 2 System (Biomerieux, Durham, NC, USA) was used to identify and determine the antibiotic susceptibility of the P. mirabilis isolates. Susceptibility results were interpreted as sensitive, intermediate, or resistant to antibiotics, according to CLSI criteria. 29 Multi-drug resistant (MDR) isolates were defined as isolates resistant to or with intermediate susceptibility to more than three classes of the following antimicrobial groups: (1) ampicillin, amoxicillin/clavulanate, or piperacillin/tazobactam; (2) cefuroxime, ceftriaxone, or cefepime; (3) carbapenems; (4) ciprofloxacin or levofloxacin; (5) gentamicin or amikacin; and (6) cotrimoxazole. 30 
Statistical analysis
All statistical analyses were performed using SPSS version 14.0 (SPSS Inc., Chicago, IL, USA). Data were analyzed using the Student t test for continuous variables and Fisher's exact test and Pearson's c 2 test for categorical variables. Significance was set at p < 0.05 using two-sided comparisons. All significant (p < 0.05) variables that were identified by univariate analysis were further analyzed by multivariable analysis for logistic regression.
Results
During the study period, a total of 740 P. mirabilis bacteremic and nonbacteremic UTI cases were evaluated, but only 656 cases remained after the exclusion of isolates from patients under 18 years of age. The causes of the bacteremia in 18 of the 85 cases of P. mirabilis bacteremia were thought to be unrelated to the initial UTI. Therefore, 67 episodes were included in the bacteremic group. Among 571 cases of P. mirabilis-induced bacteriuria, 447 episodes lacked concurrent blood culture data or were suspected to reflect colonization and were therefore excluded. Cases were matched, as much as possible, for sex and age to 124 controls (bacteriuric episodes with definitively negative blood culture results) in a 1:2 ratio. A total of 191 cases were included in our study, including 67 in the bacteremic group (35.07%) and 124 (64.9%) in the nonbacteremic group. Six patients had two episodes each during the study period (i.e., a total of 191 episodes in 185 patients).
The demographic and clinical characteristics of the patients are shown in Table 1 . Of 191 episodes, 60 patients were admitted to intensive care units (ICUs). Among these, 24 were in the bacteremic group and 36 were in the nonbacteremic group. Of these 191 episodes, 147 (77.0%) cases received imaging studies. Nearly half of the cases (49.0%) underwent abdominal sonography, and in 24.6% of cases the patient underwent an abdominal CT scan. In 2.6% of cases, the patient received only a KUB examination.
Univariate analysis revealed that bacteremic P. mirabilis UTIs are more common in patients with communityacquired infections than in those with nosocomialacquired infections (41.9% vs. 22.4%, p Z 0.011). Hydronephrosis appeared in 43.3% of patients in the bacteremic group, but in only 12.1% of those the nonbacteremic group (p < 0.001). Comparing the bacteremic group with the nonbacteremic group, a higher prevalence of urolithiasis was found in the P. mirabilis bacteremic group (44.8% vs. 24.2%, p Z 0.006). Chronic urinary catheterization was less common in patients with community-acquired infections (26.6% vs. 62.7%, p < 0.001) (data not shown). There was no obvious difference in the duration of preadmission symptoms between these two groups (p Z 0.903) ( Table 1) . Regarding the clinical presentation, the bacteremic group tended to present with hyperthermia (body temperature >38 C) or hypothermia (body temperature <36 C) (76.1% vs. 56.3%, p Z 0.011), higher blood urea nitrogen (BUN) levels (average 40.44 AE 47.57 mg/dL vs. 25.37 AE 26.37 mg/ dL, p Z 0.020), and azotemia (58.2% vs. 41.1%, p Z 0.035). A band neutrophil count >10% of the white blood cell (WBC) count was more commonly found in the bacteremic group (22.4% vs. 6.5%, p Z 0.003). There was no statistically significant difference in terms of the presence of a WBC count >12,000 /mL between the bacteremic and nonbacteremic groups (64.2% vs. 50.8%, p Z 0.105).
A higher C-reactive protein concentration was more common in the bacteremic group (160.52 AE 106.67% vs. 77.59 AE 74.19, p < 0.001). (Table 2 ).
The significant risk factors that were identified by univariate analysis were further analyzed by multivariate logistic regression. This analysis was able to identify the community source (adjusted odds ratio: 2.70; 95% CI:1.19e6.09; p Z 0.017), hydronephrosis (adjusted odds ratio: 3.22; 95% CI: 1.24e8.39; p Z 0.017), WBC band neutrophils accounting for >10% of the WBC count (adjusted odds ratio: 6.09; 95% CI: 2.07e17.94; p Z 0.001), hyperthermia or hypothermia (adjusted odds ratio: 2.21; 95% CI: 1.01e4.82; p Z 0.047), and C-reactive protein level >100 mg/L (adjusted odds ratio: 3.11; 95% CI: 1.51e6.39; p Z 0.002) as independent factors associated with an increased risk of bacteremia in patients with a P. mirabilis UTI (Table 3) .
Clinical outcomes
Seventeen patients died during their hospitalizations. The in-hospital mortality rate of P. mirabilis UTI was 8.9%. Among the 17 patients who died (total), 11 were in the bacteremic group and 6 were in the nonbacteremic group. Univariate analysis showed that a higher mortality rate was significantly associated with P. mirabilis bacteremia (16.4% vs. 4.8%, p Z 0.016), a stay in the ICU (76.5% vs. 27.0%, p < 0.001), the occurrence of a shock episode (82.4% vs. 20.1%, p < 0.001), vasopressor use (64.7% vs. 18.4%, p < 0.001 ), C-reactive protein concentration >100 mg/dL (70.6% vs. 41.4%, p Z 0.039), and a body mass index (BMI) <18.0 (47.1% vs. 18.4%, p Z 0.014). Risk factors identified by univariate analysis were entered into a multivariate logistic regression model, and this analysis identified bacteremia (adjusted odd ratios: 3.52; 95% CI: 1.00e12.40; We compared the preadmission histories of both groups. The use of antibiotics before culture collection and the duration of symptoms prior to receiving medical care were recorded. Difference in the use of antimicrobial agents to treat the bacteremic and nonbacteremic groups was of borderline significance (57.9% vs. 42.1%, p Z 0.052). From the onset of symptoms to the initiation of medical care, the difference in average duration in bacteremic and nonbacteremic groups was not statistically significant (2.29 AE 3.66 vs. 2.00 AE 2.16 days, p Z 0.903) ( Table 1) . 
Discussion
Our analysis identified independent factors associated with the increased risk of bacteremia in patients with P. mirabilis UTIs. These independent risk factors include the following: community-acquired infection, hydronephrosis, the increased presence of band neutrophils accounting for >10% of the WBC count, hyperthermia or hypothermia, and a C-reactive protein level >100 mg/L. In a previous survey, bacteremic UTI s were often associated with longer hospitalizations, more severe complications, and higher mortality rates compared with nonbacteremic UTIs. 31, 32 Several studies have surveyed the clinical presentation and laboratory manifestations of bacteremic UTIs. Leibovici et al investigated 247 older patients (median age: 75 years) and found that a high serum creatinine level, high WBC count, hyperthermia, diabetes mellitus, and low serum albumin level are more common in patients with bacteremic UTIs caused by various kinds of pathogens. 32 In contrast, Bahagon et al showed no statistically significant difference between diabetes mellitus, chronic kidney disease (CKD), or immunocompromised status as risk factors for bacteremic UTI, but both of their studies identified severe SIRS reactions as more common in the bacteremic group; 32, 33 however, the leading causative pathogen among the patients in these studies was E. coli, and their analysis was performed in patients with different pathogens. The risk factors for P. mirabilis bacteremic UTI have not been fully elucidated. 17, 34, 35 Compared with UTIs caused by E. coli, UTIs caused by Proteus spp. are often more severe and associated with a higher incidence of pyelonephritis. In Proteus spp UTIs, the urine pH is often >7.2. The majority of the bloodstream infections caused by Proteus spp. originate from a UTI and are often associated with urinary catheters. Consistent with previous studies, 32, 36 our study demonstrates that hydronephrosis, band neutrophils accounting for >10% of the WBC count, hyperthermia or hypothermia, a severe SIRS reaction, and a high C-reactive protein concentration are more common in P. mirabilis bacteremic UTIs; however, b Nosocomial infection: (1) infections occurring more than 48 hours after hospital admission or after emergency department admission, or (2) those who were referred from another hospital or healthcare facility. 26 c Kidney failure is defined as a creatinine level >1.5 mg/dL. d When the catheter had been maintained for more than 7 days. e Multidrug resistant isolates are defined as resistant or intermediately susceptible to more than three classes of the flowing antimicrobial groups: 30 (1) ampicillin, amoxicillin/clavulanate, or piperacillin/tazobactam; (2) cefuroxime, ceftriaxone, and cefepime; (3) carbapenems; (4) ciprofloxacin or levofloxacin; (5) gentamicin or amikacin; (6) cotrimoxazole.
there was no statistically significant difference in terms of diabetes mellitus, chronic obstructive pulmonary disease (COPD), or immunocompromised status. Furthermore, our results show that bacteremic P. mirabilis UTIs are more common in patients with community-acquired infections. Preadmission history of antimicrobial treatments and duration of symptoms prior to the onset of medical care of both groups were investigated, but no statistically significant difference was confirmed. In contrast, higher rates of urolithiasis and hydronephrosis were noted in patients with community-acquired infections in our cohort. At the same time, a lower proportion of chronic urinary catheterization was also noted in the community-acquired group. Thus, patients with functional urological problems, such as neurogenic bladder or urinary retention, are at a higher risk of developing hydronephrosis and urolithiasis formation and encrustation. Encrustation further blocks the lumen, obstructs flow, and causes vesicoureteral reflux, thereby inducing an ascending infection that can further develop into pyelonephritis, bacteremia, and shock. This may explain why the bacteremic P. mirabilis UTIs are more common in patients with community-acquired infections.
In our study, 17 patients died (8.9%), 11 of whom were in the bacteremic group and 6 of whom were in the nonbacteremic group. Multivariate analysis using logistic regression showed that bacteremic UTI, shock, and an extremely low BMI are independent risk factors of mortality. In our study, patients with P. mirabilis bacteremia had a higher rate of mortality than nonbacteremic patients. This finding is similar to findings in other studies on Enterobacteriaceae-causing bacteremic UTIs. 18, 36 Two previous studies have pointed out that bacteremic UTI in patients with a low serum albumin level and a severe SIRS reaction tended to be associated with poor clinical outcomes. 28, 36 Our finding that an extremely low BMI is an independent risk factor for poor clinical outcomes has also been reported in previous studies. 37, 38 The reason why we did not investigate an association between the serum albumin level and clinical outcome was because of missing clinical data from some of our patients. Our results show that an extremely low BMI is similar to a low serum albumin level in terms of its usefulness as a predictor of a poor clinical outcome. Sometimes a low BMI is superior to albumin as a clinical predictor because BMI may be more readily determined by primary care clinicians.
Our study demonstrates that isolates of P. mirabilis in nonbacteremic UTIs are less susceptible to first-generation cephalosporin and fluoroquinolone than isolates of P. mirabilis in bacteremic UTIs. In comparison with non-MDR isolates, more patients infected with MDR strains did not receive the appropriate initial antibiotic treatment; however, MDR P. mirabilis infections were not associated with poor clinical outcomes (Table 4) , and this finding has been noted in other studies. 30, 39 Endimiani et al reported that ESBL-producing P. mirabilis bloodstream infections are associated with poor outcomes. 28 Differences between these results may be because MDR P. mirabilis isolates were less common in the bacteremic group in our cohort.
The most important limitation of this study is that the number of cases was small. Another limitation is that our study is a retrospective study, and the preadmission histories of each patient (such as the classes of antibiotics used before and during treatment) were based primarily on statements provided by the patients and their families and are, therefore, difficult to interpret. Finally, missing data on serum albumin levels in some of our patients led to difficulty evaluating the association between serum albumin levels and patient's clinical outcome.
In conclusion, the independent risk factors for bacteremia-complicating P. mirabilis UTIs were determined to be the following: community-acquired infection, hydronephrosis, SIRS reaction, band neutrophils accounting for >10% of the WBC count, and a high C-reactive protein level. Bacteremic UTIs, shock, and low BMI were associated with poor clinical outcomes. We recommend that patients with the clinical presentation and risks factors mentioned above undergo further radiologic imaging studies, such as abdominal sonography or a CT scan. Further studies that include a greater number of cases may be necessary.
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